Supporting confident, evidence-informed clinical decision-making.

Trusted, evidence-based and expert-informed answers to your medication and treatment questions, right when they're needed

Try Ori
primary care physician using psychiatric decision support tool, clinician reviewing mental health treatment guidance, point-of-care psychiatric clinical support software, rapids health
AI-powered clinical decision support tool, ori rapids health

Help shape the future of Ori by Rapids Health

We’re getting ready to launch something new – and we’re looking for testers to help shape it. Get early access, influence the product, and tell us what really matters.

Interested?

Apply for early access

Create treatment plans with confidence.

Access immediate psychiatric medication information

Comprehensive guidance covers primary and adjunctive medications for depression and anxiety, sleep medications, and ADHD medications. This structured approach helps clinicians understand when and how each medication type may be used safely and effectively within an overall treatment plan.

treatment guidance for insomnia, ori by rapids health Try Ori

Structured and actionable guidance

Complex clinical presentations are translated into tailored, evidence-based management strategies for major depressive disorder (MDD), generalized anxiety disorder, ADHD and insomnia. Clear clinical rationale supports each recommendation, helping clinicians navigate treatment decisions with confidence while balancing effectiveness, safety, and individual patient needs.

treatment guidance for depression, helping nps with psychiatric diagnoses

Clarity and brevity you can act on

Clear summaries outline approved indications and common off-label uses, along with each medication’s drug class and mechanism of action. Expert-favoured treatment options are highlighted for supported psychiatric conditions, helping clinicians quickly understand where each medication fits and make informed, evidence-aligned prescribing decisions.

ori rapids health, helping drs choose antidepressants

Practical strategies for efficient planning

We provide clear, practical dosing guidance for major depressive disorder, generalized anxiety disorder, ADHD and insomnia, including how to start, adjust, and optimize medications. Guidance covers evidence-supported higher dosing ranges for select medications, appropriate timing for dose increases, and short- and long-term optimization pathways that prioritize safety and tolerability. Administration details, such as timing, frequency, and food considerations, are also included.

ai-based medication decision tool, ori by rapids health

No treatment is effective if it’s not taken

Clear tolerability ratings highlight the likelihood of common side effects, such as weight gain, sexual dysfunction, daytime sedation, and gastrointestinal distress. These at-a-glance insights help clinicians quickly assess risk profiles and make informed treatment decisions tailored to each patient.

Real world clinical practice insights you can trust

Provides additional clinical benefits beyond primary therapeutic effects e.g., anxious distress, cognitive functioning, fatigue/loss of energy, pain syndromes and general and safety insights with a practical focus.

 

ai clinical support management tools for general practitioners

Access immediate psychiatric medication information

Comprehensive guidance covers primary and adjunctive medications for depression and anxiety, sleep medications, and ADHD medications. This structured approach helps clinicians understand when and how each medication type may be used safely and effectively within an overall treatment plan.

treatment guidance for insomnia, ori by rapids health Try Ori

Structured and actionable guidance

Complex clinical presentations are translated into tailored, evidence-based management strategies for major depressive disorder (MDD), generalized anxiety disorder, ADHD and insomnia. Clear clinical rationale supports each recommendation, helping clinicians navigate treatment decisions with confidence while balancing effectiveness, safety, and individual patient needs.

treatment guidance for depression, helping nps with psychiatric diagnoses

Clarity and brevity you can act on

Clear summaries outline approved indications and common off-label uses, along with each medication’s drug class and mechanism of action. Expert-favoured treatment options are highlighted for supported psychiatric conditions, helping clinicians quickly understand where each medication fits and make informed, evidence-aligned prescribing decisions.

ori rapids health, helping drs choose antidepressants

Practical strategies for efficient planning

We provide clear, practical dosing guidance for major depressive disorder, generalized anxiety disorder, ADHD and insomnia, including how to start, adjust, and optimize medications. Guidance covers evidence-supported higher dosing ranges for select medications, appropriate timing for dose increases, and short- and long-term optimization pathways that prioritize safety and tolerability. Administration details, such as timing, frequency, and food considerations, are also included.

ai-based medication decision tool, ori by rapids health

No treatment is effective if it’s not taken

Clear tolerability ratings highlight the likelihood of common side effects, such as weight gain, sexual dysfunction, daytime sedation, and gastrointestinal distress. These at-a-glance insights help clinicians quickly assess risk profiles and make informed treatment decisions tailored to each patient.

Real world clinical practice insights you can trust

Provides additional clinical benefits beyond primary therapeutic effects e.g., anxious distress, cognitive functioning, fatigue/loss of energy, pain syndromes and general and safety insights with a practical focus.

 

ai clinical support management tools for general practitioners
evidence informed guidance, ori by rapids health, ai decision support tools mental illness

Faster answers to your pressing clinical questions.

Keeping up-to-date with evolving psychiatric knowledge can be difficult. It takes time to sift through resources, and specialist consults can be hard to get. Ori by Rapids Health delivers trusted, evidence-based and expert-informed guidance instantly, so you can more effectively help your patients – without the wait.

Trusted, timely clinical guidance for mental healthcare.

Fast & actionable

Questions about medication tolerability, dosing, clinical benefits, efficacy? Get instant answers to your medication-related questions, so you spend less time on research and more time providing patient care.

Practice-informed evidence

Wading through clinical papers and guidelines, product monographs, drug interaction databases? We’ve taken care of that, so all you have to do is ask Ori.

Specialized

We bridge the gap between your clinical experience and the latest clinically validated insights. Ori is like having a specialist on hand, when you need them.

Your clinical practice resource for treating psychiatric disorders.

Psychiatry is complex. Ori is here to help.

Try Ori

mental illness rapid assessments, ori by rapids health

Your questions, the way you ask them.

Our conversational interface makes it easy to ask questions about treatments for psychiatric disorders.

Ori by Rapids Health, treatment for anxiety and depression

How can we help you? Let’s start with depression and anxiety.

Ori covers treatment information for MDD and GAD. Soon we’ll be adding comprehensive diagnostic and treatment knowledge for insomnia and ADHD.

ori by rapids health, ai decision support tool for depression treatment

Save and share your conversations.

Easily copy answers to add to your patient notes. Ori can format answers in a way that works best for you, as a table, or bulleted list, for example.

FAQ – Your questions, answered.

Answers to common inquiries about products from Rapids Health.

Browse by Category

Ori

Ori by Rapids Health is an AI-powered clinical decision support tool that makes evidence-based and expert-informed psychiatric knowledge available to clinicians.

Keeping up-to-date with evolving psychiatric knowledge can be difficult. It takes time to sift through resources, and specialist consults can be hard to get. Ori delivers trusted, evidence-based and expert-informed guidance instantly, so you can more effectively help your patients – without the wait.

At this time, you can ask questions about psychiatric medications and decision support related to pharmacotherapy, as well as questions related to clinical presentations to generate structured treatment guidance for MDD and GAD. New disorders will be added soon. 

Ori provides guidance related to major depressive disorder (MDD) and generalized anxiety disorder (GAD). Guidance related to insomnia, ADHD, and bipolar disorder will be added in the coming months.

The Rapids knowledge base is a curated repository of clinical information on psychiatric medications and comprehensive treatment guidance sourced from published guidelines, peer-reviewed research, and clinical expertise. The knowledge has been selected by leaders in the field of psychiatry and psychopharmacology and logic-driven treatment guidance has been validated by a panel of psychiatric experts.

Ori is an AI-powered clinical decision support tool that makes evidence-based and expert-informed psychiatric knowledge accessible instantly, safely, and in context, to support confident and informed clinical decision-making. Soli (known to many as RAPIDS) is a clinical decision support service that automates patient assessments and provides evidence-based treatment and diagnostic guidance, in a report, personalized for each patient.

Information about Ori is updated regularly; go here to test Ori or join our beta waitlist.

Soli (Rapids)

Soli is the new name for Rapids, our clinical decision support service that provides personalized diagnostic and treatment guidance in a detailed report to support clinical decision-making.

Using clinical scales is standard psychiatric care. Soli automates scale delivery, streamlines the collection of patient information to support a DSM-5-TR diagnosis, and automates follow-up monitoring. Evidence-based, clinically informed guidance reduces administrative burden, accelerates treatment decisions, and provides patient education to support engagement, shared decision-making, and adherence.

Patients aged 18-65 with symptoms of mood disorders (MDD and bipolar), anxiety, insomnia and/or ADHD can benefit from Soli.

Soli subscribers have access to Soli smart forms for the following EMRs: Accuro, CHR, Juno, MedAccess, Medesync, MOIS, Myle, PS Suite, Oscar, Plexia and Profile.

Soli (the product you know as RAPIDS) will continue to run exactly as it always has. We have updated the name and brand to bring it in line with our new solution, Ori, that is now available for testing. We’ve launched a new website, and we now offer online access to customer support and resources. Summary of changes:

  • the product is now called Soli
  • we have updated our brand (you may have noticed, the website looks quite different!)
  • you can contact us now through our new service desk (i.e. not via email)
  • the Terms and Conditions have been updated.

You should receive communications from Rapids in your email about these changes and the updated Terms of Use. If you have not, please contact us.

Soli (known to many as Rapids) is a clinical decision support service that automates patient assessments and provides evidence-based treatment and diagnostic guidance, in a report, which is personalized for each patient. Ori is a new AI-powered clinical decision support tool that makes evidence-based and expert-informed psychiatric knowledge accessible instantly, safely, and in context, to support confident and informed clinical decision-making.

Yes, Rapids – now Soli – is available. See here to subscribe.

Early access

We’re inviting eligible users to join our alpha program and join the waitlist for early access to Ori when beta is released this spring. Learn more

We are recruiting for eligible users to join the alpha test group for Ori now. Currently eligible are Canadian family physicians and nurse practitioners. Ori will be available in beta to a broader group of Canadian prescribers starting Spring 2026; please join the waitlist to be first in line – no cost involved.

There is no cost for Ori or Soli at this time.

Not ready to join the alpha and beta programs? Want to keep up with exciting product updates? Join our mailing list and we’ll keep you updated.

Ready for psychiatric guidance at your fingertips?

Join the thousands of clinicians who rely on specialized guidance to support better patient care.

Try Ori
ai-decision support tool mental illness, rapids health canada, tools for psychiatric diagnosis